Estrogen receptor in operable breast cancer with negative axillary lymph
Descripción del Articulo
OBJECTIVES: To determine the prognostic significance of the state of estrogen receptor (ER) and identify prognostic factors related to the five-year survival in patients with operable breast cancer with negative axillary nodes (CMOGAN). DESIGN: Retrospective. MATERIALS AND METHODS: 37 patients under...
| Autores: | , , , , , |
|---|---|
| Formato: | artículo |
| Fecha de Publicación: | 2015 |
| Institución: | Sociedad Peruana de Obstetricia y Ginecología |
| Repositorio: | Revista SPOG - Revista Peruana de Ginecología y Obstetricia |
| Lenguaje: | español |
| OAI Identifier: | oai:ojs.spog:article/914 |
| Enlace del recurso: | http://www.spog.org.pe/web/revista/index.php/RPGO/article/view/914 |
| Nivel de acceso: | acceso abierto |
| Sumario: | OBJECTIVES: To determine the prognostic significance of the state of estrogen receptor (ER) and identify prognostic factors related to the five-year survival in patients with operable breast cancer with negative axillary nodes (CMOGAN). DESIGN: Retrospective. MATERIALS AND METHODS: 37 patients undergoing CMOGAN classical radical mastectomy (n = 28) or modified (n = 9) is evaluated in the Bethlehem Hospital from 1966 to 1995. estrogen receptor status was determined according to immunohistochemical method standard. RESULTS: The mean age was 48 ± 11.1 years. Four cases it had thirty-three stage I and stage II. Seven cases were ER (+) and thirty RE (-). In patients with ER (-) by univariate analysis using the log-rank test, only the type of mastectomy was significantly related to the five-year survival (p = 0.046). In the multivariate Cox analysis, histological grade (p = 0.0361), nuclear grade (p = 0.0361) and miotic index (p = 0.0239) were factors statistically associated with survival. The five-year survival in patients with CMOGAN and RE (+) was 100% and in patients RE (-) 65%. CONCLUSION: The histological and nuclear grade, and mitotic index significantly influence the survival of patients with CMOGAN and RE (-). |
|---|
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).